NASDAQ:ALQA - Alliqua Biomedical Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$2.45 -0.01 (-0.41 %)
(As of 04/26/2019 06:00 AM ET)
Previous Close$2.46
Today's Range$2.43 - $2.5151
52-Week Range$1.55 - $5.24
Volume25,938 shs
Average Volume215,311 shs
Market Capitalization$12.26 million
P/E RatioN/A
Dividend YieldN/A
Beta1.95
Alliqua BioMedical, Inc. develops, manufactures, and markets high water content, electron beam cross-linked, and aqueous polymer hydrogels or gels used in wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It also provides contract manufacturing services to the OEM market. The company is headquartered in Langhorne, Pennsylvania.

Receive ALQA News and Ratings via Email

Sign-up to receive the latest news and ratings for ALQA and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:ALQA
CUSIPN/A
Phone215-702-8550

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.22 million
Book Value$1.65 per share

Profitability

Net Income$-8,420,000.00

Miscellaneous

Employees6
Market Cap$12.26 million
Next Earnings Date5/13/2019 (Estimated)
OptionableNot Optionable

Alliqua Biomedical (NASDAQ:ALQA) Frequently Asked Questions

What is Alliqua Biomedical's stock symbol?

Alliqua Biomedical trades on the NASDAQ under the ticker symbol "ALQA."

When did Alliqua Biomedical's stock split? How did Alliqua Biomedical's stock split work?

Shares of Alliqua Biomedical reverse split on the morning of Friday, October 6th 2017. The 1-10 reverse split was announced on Thursday, October 5th 2017. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, October 5th 2017. An investor that had 100 shares of Alliqua Biomedical stock prior to the reverse split would have 10 shares after the split.

How were Alliqua Biomedical's earnings last quarter?

Alliqua Biomedical Inc (NASDAQ:ALQA) issued its earnings results on Tuesday, August, 9th. The company reported $0.50 earnings per share for the quarter, beating analysts' consensus estimates of ($2.70) by $3.20. The business earned $5.50 million during the quarter, compared to analyst estimates of $5.38 million. View Alliqua Biomedical's Earnings History.

When is Alliqua Biomedical's next earnings date?

Alliqua Biomedical is scheduled to release their next quarterly earnings announcement on Monday, May 13th 2019. View Earnings Estimates for Alliqua Biomedical.

What is the consensus analysts' recommendation for Alliqua Biomedical?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Alliqua Biomedical in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Alliqua Biomedical.

Has Alliqua Biomedical been receiving favorable news coverage?

Media headlines about ALQA stock have trended neutral recently, InfoTrie Sentiment reports. The research group identifies negative and positive press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Alliqua Biomedical earned a news sentiment score of 0.1 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the stock's share price in the next few days.

Who are some of Alliqua Biomedical's key competitors?

What other stocks do shareholders of Alliqua Biomedical own?

Who are Alliqua Biomedical's key executives?

Alliqua Biomedical's management team includes the folowing people:
  • Mr. David Ian Johnson, Pres, CEO, Principal Financial Officer & Director (Age 61)
  • Dr. Phillip D. Forman M.D., DPM, Exec. VP of Clinical Affairs (Age 60)
  • Mr. Joseph M. Warusz, CFO, Treasurer & Sec. (Age 63)

How do I buy shares of Alliqua Biomedical?

Shares of ALQA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Alliqua Biomedical's stock price today?

One share of ALQA stock can currently be purchased for approximately $2.45.

How big of a company is Alliqua Biomedical?

Alliqua Biomedical has a market capitalization of $12.26 million and generates $2.22 million in revenue each year. The company earns $-8,420,000.00 in net income (profit) each year or ($6.49) on an earnings per share basis. Alliqua Biomedical employs 6 workers across the globe.

What is Alliqua Biomedical's official website?

The official website for Alliqua Biomedical is http://www.alliqua.com.

How can I contact Alliqua Biomedical?

Alliqua Biomedical's mailing address is 2150 CABOT BLVD WEST SUITE B, LANGHORNE PA, 19047. The company can be reached via phone at 215-702-8550 or via email at [email protected]


MarketBeat Community Rating for Alliqua Biomedical (NASDAQ ALQA)

Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  295 (Vote Outperform)
Underperform Votes:  183 (Vote Underperform)
Total Votes:  478
MarketBeat's community ratings are surveys of what our community members think about Alliqua Biomedical and other stocks. Vote "Outperform" if you believe ALQA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ALQA will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 4/26/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel